Acute interstitial nephritis with membranous nephropathy in bucillamine-treated rheumatoid arthritis

CEN Case Reports
Naoki TakamatsuYayoi Ogawa

Abstract

In bucillamine-treated patients, persistent proteinuria caused by membranous nephropathy (MN) is a major adverse effect affecting the kidneys. We experienced a case of acute interstitial nephritis (AIN) with MN caused by bucillamine. An 81-year-old Japanese woman with a past medical history of rheumatoid arthritis and hypertension presented with a fever, epigastric pain, and nausea of 1 week's duration. She had commenced bucillamine 4 months earlier. At the time of admission, her baseline creatinine (0.8 mg/dl) had risen to 6.8 mg/dl. A renal biopsy revealed AIN with concomitant MN. Renal function gradually improved after bucillamine administration was stopped. In addition to MN, bucillamine can cause AIN, which requires a renal biopsy for definitive diagnosis. Given the host of pathological findings that tend to develop in patients using bucillamine, patients receiving the drug who present with symptoms of acute kidney injury should undergo a renal biopsy to determine the presence of AIN.

References

Nov 10, 2000·Lancet·I R Edwards, J K Aronson
Jul 28, 2001·Kidney International·J Rossert
Mar 29, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kiyotaka NagahamaAkira Yamada
Dec 14, 2006·Kidney International·U C Brewster, M A Perazella
Mar 26, 2010·Kidney International·Manuel Praga, Ester González
Sep 4, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Ying TanMing-Hui Zhao
Jul 5, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marian GoicoecheaUNKNOWN Spanish Registry of Glomerulonephritis
Jun 15, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Angela K MuriithiSamih H Nasr
Sep 4, 2014·Kidney International·Angela K MuriithiSamih H Nasr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anal Dysplasia

Anal dysplasia is a precancerous condition in which some cells within the anus transform into abnormal cells. Discover the latest research on anal dysplasia here.